Total
0
Shares
Cellmid (ASX:CDY) - CEO, Maria Halasz
CEO, Maria Halasz
Source: Maria Halasz / LinkedIn
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Cellmid (CDY) pens a deal to acquire BLC Cosmetics through a share sale agreement
  • The distributor of the premium health and beauty brand will be acquired through cash and shares in two tranches, with the first totalling $3 million
  • Cellmid says the acquisition is a major milestone in its growth strategy to build a profitable, market-leading, anti-ageing beauty tech company
  • Cellmid says it’s fully funded to make payments through its reserves without any further capital raising
  • Cellmid is up 17.7 per cent, trading at 6 cents at 2:37 pm AEST

Cellmid (CDY) has penned an agreement to acquire BLC Cosmetics.

The distributor of the premium health and beauty brand will be solely acquired through a share sale agreement, made up of cash and shares in two tranches.

As part of the first tranche, Cellmid will pay $3 million on settlement, expected in late October, made up of $1 million in cash from the company’s existing cash reserves and $2 million by issuing 32,786,885 shares at 6.1 cents each.

Cellmid said the acquisition was a major milestone in its growth strategy to build a profitable, market-leading, anti-ageing beauty tech company with premium products across hair care and skin care.

BLC Cosmetics is said to be on the rise, with around $7 million in revenue. This revenue continued to grow in FY21, despite the pandemic, which it says was largely driven by its professional distribution channels.

Additionally, the company said with an expanded product range, it would be able to fully utilise its recently established e-commerce capabilities, where achieving scale is significantly enhanced by the merged product offering.

 “The acquisition of BLC will enable us to effectively double our revenue immediately, progress towards profitability and achieve the necessary scale in the market to cross-sell our premium product range in our joint distribution channels,” Cellmid CEO Maria Halasz said.

Cellmid said it was fully funded and would be making cash payments related to the deal from its reserves, without any further capital raising.

Cellmid was up up 17.7 per cent, trading at 6 cents at 2:37 pm AEST.

CDY by the numbers
More From The Market Herald
BetMakers (ASX:BET) - CEO, Todd Buckingham

" BetMakers Technology (ASX:BET) posts record revenue over September quarter

BetMakers Technology (BET) has opened the trading day red despite revealing record revenue for the three months to the end of September in
Fiji Kava (ASZ:FIJ) - CEO, Anthony Noble

" Fiji Kava (ASX:FIJ) appoints Network Nutrition as US marketing partner

Medicinal kava company Fiji Kava (FIJ) has appointed Network Nutrition as their exclusive marketing partner in the United States for speciality ingredient sales.
Harris Technology (ASX:HT8) - CEO, Garrison Huang

" Harris Technology Group (ASX:HT8) achieves record quarterly sales

Harris Technology Group (HT8) achieved a record $15.1 million in quarterly sales in the September quarter.

" Qantas (ASX:QAN) and Jetstar resume international flights early

Qantas (QAN) and Jetstar are preparing to resume international flights from Sydney ahead of schedule.